tiprankstipranks
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market
Holding WST?
Track your performance easily

West Pharmaceutical Services (WST) Financial Statements

677 Followers

West Pharmaceutical Services Financial Overview

West Pharmaceutical Services's market cap is currently ―. The company's EPS TTM is $6.741; its P/E ratio is ―; and it has a dividend yield of 0.24%. West Pharmaceutical Services is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $1.72. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 746.90M$ 702.10M$ 695.40M$ 732.00M$ 747.40M
Gross Profit$ 264.70M$ 230.00M$ 230.20M$ 278.20M$ 288.30M
EBIT$ 169.10M$ 133.20M$ 136.40M$ 169.40M$ 193.60M
EBITDA$ 209.30M$ 172.10M$ 172.00M$ 205.30M$ 229.30M
Net Income Common Stockholders$ 136.00M$ 116.10M$ 115.30M$ 137.00M$ 161.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 490.90M$ 446.20M$ 601.80M$ 853.90M$ 898.60M
Total Assets$ 3.68B$ 3.49B$ 3.60B$ 3.83B$ 3.75B
Total Debt$ 304.80M$ 310.70M$ 306.60M$ 309.00M$ 306.80M
Net Debt$ -186.10M$ -135.50M$ -295.20M$ -544.90M$ -591.80M
Total Liabilities$ 923.00M$ 912.60M$ 921.70M$ 948.50M$ 886.50M
Stockholders Equity$ 2.75B$ 2.58B$ 2.68B$ 2.88B$ 2.87B
Cash Flow-
Free Cash Flow$ 98.80M$ 64.80M$ 27.60M$ 130.40M$ 134.30M
Operating Cash Flow$ 180.10M$ 165.00M$ 118.20M$ 239.10M$ 230.10M
Investing Cash Flow$ -82.10M$ -101.20M$ -90.60M$ -108.80M$ -95.70M
Financing Cash Flow$ -64.40M$ -218.30M$ -271.00M$ -189.50M$ -22.30M
Currency in USD

West Pharmaceutical Services Earnings and Revenue History

West Pharmaceutical Services Debt to Assets

West Pharmaceutical Services Cash Flow

West Pharmaceutical Services Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis